In addition, depletion of T lymphocytes, particularly CD8+ cytotoxic T lymphocytes (CTL), leads to impaired tumor rejection [3] and the control of dormant disseminated metastatic cells [4,5,6]. The gene discussed is CD8A; the disease is neoplasm.